Related Experiment Video
Updated: Feb 7, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Left Atrial Appendages Occlusion: Current Status and Prospective
Sharan Prakash Sharma1, Peter Park1, Dhanunjaya Lakkireddy2
1Kansas City Heart Rhythm Institute, Overland Park, KS, USA.
Insights
Left atrial appendage occlusion (LAAO) offers an alternative to oral anticoagulation for stroke prevention in atrial fibrillation (AF) patients with bleeding risks. While promising, device thrombosis remains a concern, necessitating further research on comparative effectiveness and optimal patient selection.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Atrial fibrillation (AF) poses a significant stroke risk, with oral anticoagulation (OAC) being a primary preventive measure.
- Bleeding complications limit OAC use in a substantial proportion of AF patients.
- The left atrial appendage (LAA) is a common source of emboli in nonvalvular AF.
Purpose of the Study:
- To review the current evidence on the efficacy and safety of various left atrial appendage occlusion (LAAO) devices.
- To explore the future directions for LAAO research and clinical application.
Main Methods:
- Review of available randomized controlled trials and observational data on LAAO devices.
- Analysis of long-term outcomes and complications associated with LAAO.
- Discussion of comparative effectiveness and patient selection criteria.
Main Results:
- LAAO provides an alternative stroke prophylaxis for AF patients unable to tolerate OAC.
- Watchman and Amulet are commonly used LAAO devices, with limited randomized data for some.
- Long-term data suggest promising results, but device-related thrombosis is a notable complication.
Conclusions:
- LAAO is a viable alternative for stroke prevention in select AF patients.
- Further research is needed on comparative effectiveness, optimal patient selection, and post-procedural management.
- Addressing device-related thrombosis is crucial for improving LAAO outcomes.
Abstract:
Stroke continues to be a major cause of morbidity and mortality in atrial fibrillation (AF) patients. Oral anticoagulation (OAC) provides protection against stroke and peripheral embolization in AF but significant proportion of patients could not be started on anticoagulation because of bleeding complications. Left atrial appendage harbors clot in about 90% of nonvalvular AF. The advent of left atrial appendage occlusion (LAAO) techniques has provided these patients with alternative to OAC for stroke prophylaxis. Multiple LAAO devices are currently available with Watchman and Amulet being the most commonly used in clinical practice. Randomized studies are available for Watchman device only. Data on Amplatzer Cardiac Plug, Amulet and Lariat devices are limited by the paucity of randomized data. Long-term data on different LAAO techniques are showing promising results. Device related thrombosis continues to be a serious complication associated with LAAO. Future studies should look into comparative effectiveness between different LAAO techniques, optimal patient selection, risk of complications, and anticoagulant treatment after LAAO. This article aims to provide current available evidence on efficacy and safety of different LAAO devices and future prospective.
Related Concept Videos
Surface Appendages of Archaea
Marcia's Theory of Identity Status
Electrical Current
Current Density
Eddy Currents
Other major applications of eddy currents appear in metal detectors and the braking systems of trains and roller...
Displacement Current

